Biotechnology makes it possible to innovate and improve the health and quality of life of thousands of patients across the country.
Specializing in the field of biotechnology, our company was established in 2012 focusing on pharmaceutical biotechnology. Since then, we have established strategic partnerships that allow us to access cutting-edge technology and training, strengthening our ability to produce and commercialize highly complex biological and biosimilar medicines.
Our work will enable Brazil to master the technology for manufacturing biopharmaceuticals, overcoming our external dependence on this type of medicine. We will be sovereign in this strategic field for the health sector. Our employees are motivated by the pride of actively participating in this transformation that we are leading in the healthcare sector.
We are motivated by the pride of being part of the transformation in health in Brazil.
Bionovis Team
Biopharmaceuticals represent a special category of medicines, which are derived from biological processes that involve the use of genetically modified cells to produce therapeutic proteins. Thanks to advances in biotechnology, such as recombinant DNA technology, we have the ability to create highly complex biological medicines.
Essentially using genetic engineering techniques that allow cells from animals, plants or microorganisms, or even entire organisms, to produce the desired medicine.
Biopharmaceuticals obtained from animal fluids or tissues are biological products derived from living organisms. This category of biopharmaceuticals includes a variety of therapeutic substances, such as monoclonal antibodies, hormones and growth factors, which are extracted or produced from biological fluids, such as blood, or from animal tissues, such as organs and glands.
Biological and biosimilar medicines play a crucial role in modern medicine. They are essential in the treatment of various types of cancer, autoimmune diseases and a variety of other pathologies. Biotechnology therefore not only provides the basis for the production of these medicines, but also opens the door to more effective and personalized treatments in the future. With continued commitment and research, we continue to expand the horizons of medicine and improve the quality of life for patients around the world.
Bionovis is a pioneer in the production and commercialization of biological and biosimilar medicines.
Our search for scientific innovations and highly complex medicines aims to build a healthier Brazil and world for everyone.
© 2025 Bionovis. Companhia Brasileira de Biotecnologia Farmacêutica.
